AQR Arbitrage’s Apellis Pharmaceuticals APLS Stock Holding History

AQR Arbitrage’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-146,604	Closed	-$5.9M	–	640
2026 Q1	$5.9M	Buy	+146,604	New	+$3.16M	0.1%	235

Other funds holding APLS

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

AQR Arbitrage's APLS Position: Q2 2026 in Review

AQR Arbitrage sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 146,604 shares — an estimated $5.9M sold.

AQR Arbitrage first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $5.9M in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

AQR Arbitrage reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
AQR Arbitrage sold 146,604 Apellis Pharmaceuticals shares in Q2 2026, an estimated $5.9M.
AQR Arbitrage first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
AQR Arbitrage's Apellis Pharmaceuticals position peaked at $5.9M in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on AQR Arbitrage's 13F filing for Q2 2026, filed 14 Aug 2026.